Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Does Billionaire Nelson Peltz See Something In E I Du Pont De Nemours And Co (DD)?

The New York Times’s Andrew Ross Sorkin mentioned in an interview with billionaire Nelson Peltz of Trian Partners at the Delivering Alpha conference that Sorkin has sources indicating that Trian has been buying shares of E I Du Pont De Nemours And Co (NYSE:DD). Peltz refused to comment before the interview moved on to his plan to combine Mondelez International Inc (NASDAQ:MDLZ) and Kraft Foods Group Inc (NASDAQ:KRFT). DuPont’s stock popped on the news, and even after retreating a bit was still up about 5% on the day. According to our database of quarterly 13F filings, which we track as part of our work developing investment strategies (including our small cap strategy, which we have found outperforms the S&P 500 by an average of 18 percentage points per year), Peltz and his team had not owned any shares of E I Du Pont De Nemours And Co (NYSE:DD) as of the end of March (find Peltz’s favorite stocks from the filing).

Interest from other notable investors in E I Du Pont De Nemours And Co (NYSE:DD) was somewhat limited in the first quarter of 2013. Billionaire Steve Cohen’s SAC Capital Advisors increased its stake in the company to about 950,000 shares (see Cohen’s stock picks). The only other filer we track which owned more than $30 million worth of the stock at that time was Levin Capital Strategies, which is managed by John Levin (research more stocks Levin owned).

TRIAN PARTNERSE I Du Pont De Nemours And Co (NYSE:DD) is a diversified company, with business segments ranging from agricultural inputs to industrial chemicals and materials. Its reported revenue was up only slightly in the first quarter of 2013 versus a year earlier, and earnings from continuing operations were about flat as well. At its current price DuPont is valued at 13 times forward earnings estimates, which seems about right for a stagnant business. The company recently increased its quarterly dividend payment to 45 cents per share, making for a dividend yield of 3.3%.

The most obvious activist move that Peltz could be pushing for is a breakup of E I Du Pont De Nemours And Co (NYSE:DD). For example, the company’s Agriculture segment- which contributed 45% of revenue and 66% of segment operating income in Q1 2013- could be separated from the lower-margin, lower-growth remainder of the company. Both volume and price in agriculture have been growing, resulting in double-digit sales growth in Q1 relative to a year ago. If this unit were independently traded it might well be compared to Monsanto Company (NYSE:MON), whose trailing P/E is 22 even though its recent reports show little change in revenue or earnings compared to a year ago. The remainder of the company could focus on cash generation, with management potentially being able to improve the more industrial related operations. Of course, it’s also possible that this is merely a value related move and that Peltz believes the market does not fully appreciate the strength of the agricultural business or other E I Du Pont De Nemours And Co (NYSE:DD) assets; he could also want DuPont to engage in an acquisition strategy. In addition, any activist plans Trian may have would likely need to be accepted by management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.